Format

Send to

Choose Destination
Teratology. 1994 Jun;49(6):446-7.

FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee.

[No authors listed]

Abstract

The Teratology Society believes that the current FDA Use-in-Pregnancy Ratings should be abandoned. The Society recommends that drug labeling should include narrative statements that summarize and interpret available data regarding hazards of developmental toxicity and provide estimates of potential teratogenic risk.

PMID:
7747265
DOI:
10.1002/tera.1420490603
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center